Biosimilars In Europe: Big Pharma Playing Catch Up In Own Backyard
Executive Summary
As South Korea’s Celltrion Healthcare steals a march with more launches of its biosimilar monoclonal antibody infliximab in major countries in Europe, local companies believe it’s not too late to enter the game.